Baker Bros. Advisors as of Sept. 30, 2024
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 93 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BeiGene Sponsored Adr (BGNE) | 24.6 | $2.4B | 11M | 224.51 | |
| Incyte Corporation (INCY) | 21.1 | $2.0B | 31M | 66.10 | |
| ACADIA Pharmaceuticals (ACAD) | 6.8 | $660M | 43M | 15.38 | |
| Summit Therapeutics (SMMT) | 5.5 | $535M | 24M | 21.90 | |
| Madrigal Pharmaceuticals (MDGL) | 4.3 | $419M | 2.0M | 212.22 | |
| Revolution Medicines (RVMD) | 3.6 | $343M | 7.6M | 45.35 | |
| Rhythm Pharmaceuticals (RYTM) | 3.5 | $335M | 6.4M | 52.39 | |
| Insmed Incorporated Com Par $.01 (INSM) | 3.3 | $322M | 4.4M | 73.00 | |
| Kymera Therapeutics (KYMR) | 2.9 | $284M | 6.0M | 47.33 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.2 | $213M | 9.4M | 22.63 | |
| Edgewise Therapeutics (EWTX) | 1.6 | $156M | 5.8M | 26.69 | |
| Replimune Group (REPL) | 1.3 | $121M | 11M | 10.96 | |
| Alkermes SHS (ALKS) | 1.2 | $117M | 4.2M | 27.99 | |
| Denali Therapeutics (DNLI) | 1.1 | $109M | 3.7M | 29.13 | |
| Insmed Incorporated Note 0.75% 6/1/2028 (Principal) | 1.0 | $98M | 43M | 2.29 | |
| Ultragenyx Pharmaceutical (RARE) | 0.9 | $88M | 1.6M | 55.55 | |
| Nurix Therapeutics (NRIX) | 0.9 | $87M | 3.9M | 22.47 | |
| Entrada Therapeutics (TRDA) | 0.8 | $78M | 4.9M | 15.98 | |
| Immatics SHS (IMTX) | 0.8 | $74M | 6.4M | 11.41 | |
| Abcellera Biologics (ABCL) | 0.7 | $72M | 28M | 2.60 | |
| Kiniksa Pharmaceuticals International Ord Shs Cl A (KNSA) | 0.7 | $70M | 2.8M | 24.99 | |
| Igm Biosciences (IGMS) | 0.7 | $68M | 4.1M | 16.54 | |
| argenx SE Sponsored Adr (ARGX) | 0.6 | $61M | 112k | 542.08 | |
| Stoke Therapeutics (STOK) | 0.6 | $54M | 4.4M | 12.29 | |
| Immunocore Holdings Ads (IMCR) | 0.5 | $47M | 1.5M | 31.13 | |
| Kodiak Sciences (KOD) | 0.5 | $45M | 17M | 2.61 | |
| Sera Prognostics Class A Com (SERA) | 0.4 | $42M | 5.4M | 7.80 | |
| CRISPR Therapeutics Namen Akt (CRSP) | 0.4 | $40M | 843k | 46.98 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $39M | 994k | 39.37 | |
| Immunovant (IMVT) | 0.4 | $35M | 1.2M | 28.51 | |
| Cerus Corporation (CERS) | 0.4 | $34M | 20M | 1.74 | |
| Ideaya Biosciences (IDYA) | 0.3 | $34M | 1.1M | 31.68 | |
| Roivant Sciences SHS (ROIV) | 0.3 | $32M | 2.8M | 11.54 | |
| Akero Therapeutics (AKRO) | 0.3 | $32M | 1.1M | 28.69 | |
| Krystal Biotech (KRYS) | 0.3 | $31M | 170k | 182.03 | |
| Celcuity (CELC) | 0.3 | $28M | 1.9M | 14.91 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $26M | 4.9M | 5.30 | |
| Dyne Therapeutics (DYN) | 0.3 | $24M | 672k | 35.92 | |
| Biomea Fusion (BMEA) | 0.2 | $21M | 2.1M | 10.10 | |
| Bicara Therapeutics | 0.2 | $21M | 833k | 25.47 | |
| Prelude Therapeutics (PRLD) | 0.2 | $21M | 10M | 2.07 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $20M | 1.2M | 15.99 | |
| Neurogene (NGNE) | 0.2 | $19M | 456k | 41.96 | |
| Praxis Precision Medicines I (PRAX) | 0.2 | $19M | 323k | 57.54 | |
| Alumis (ALMS) | 0.2 | $17M | 1.6M | 10.68 | |
| Merus N V (MRUS) | 0.2 | $15M | 300k | 49.96 | |
| Tscan Therapeutics (TCRX) | 0.1 | $14M | 2.8M | 4.98 | |
| Neumora Therapeutics (NMRA) | 0.1 | $14M | 1.0M | 13.21 | |
| Xencor (XNCR) | 0.1 | $14M | 670k | 20.11 | |
| 2seventy bio Common Stock (TSVT) | 0.1 | $12M | 2.5M | 4.72 | |
| Fate Therapeutics (FATE) | 0.1 | $11M | 3.0M | 3.50 | |
| Arvinas Ord (ARVN) | 0.1 | $10M | 406k | 24.63 | |
| Sana Biotechnology (SANA) | 0.1 | $9.9M | 2.4M | 4.16 | |
| Design Therapeutics (DSGN) | 0.1 | $9.4M | 1.7M | 5.38 | |
| Ionis Pharmaceuticals (IONS) | 0.1 | $9.0M | 224k | 40.06 | |
| Opthea Sponsored Ads (OPT) | 0.1 | $8.8M | 2.2M | 4.07 | |
| Celldex Therapeutics (CLDX) | 0.1 | $8.4M | 248k | 33.99 | |
| Relay Therapeutics (RLAY) | 0.1 | $8.2M | 1.2M | 7.08 | |
| Verve Therapeutics (VERV) | 0.1 | $8.2M | 1.7M | 4.84 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $8.0M | 4.0M | 2.01 | |
| Mirum Pharmaceuticals (MIRM) | 0.1 | $7.4M | 191k | 39.00 | |
| Contineum Therapeutics Cl A (CTNM) | 0.1 | $6.0M | 313k | 19.14 | |
| Tango Therapeutics (TNGX) | 0.1 | $5.8M | 750k | 7.70 | |
| Skye Bioscience (SKYE) | 0.1 | $5.6M | 1.4M | 3.91 | |
| Vaxcyte (PCVX) | 0.1 | $5.6M | 49k | 114.27 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.1 | $5.3M | 104k | 51.10 | |
| DBV Technologies Sponsored Adr (DBVT) | 0.1 | $5.1M | 7.3M | 0.70 | |
| Kala Pharmaceuticals (KALA) | 0.1 | $5.1M | 891k | 5.70 | |
| Generation Bio (GBIO) | 0.0 | $4.8M | 1.9M | 2.47 | |
| Alector (ALEC) | 0.0 | $4.3M | 927k | 4.66 | |
| Prime Medicine (PRME) | 0.0 | $4.0M | 1.0M | 3.87 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.0 | $3.8M | 1.4M | 2.77 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $3.8M | 86k | 43.89 | |
| Arcturus Therapeutics Hldg I (ARCT) | 0.0 | $3.5M | 151k | 23.21 | |
| Hookipa Pharma (HOOK) | 0.0 | $3.5M | 813k | 4.30 | |
| Leap Therapeutics (LPTX) | 0.0 | $3.0M | 1.2M | 2.57 | |
| Enliven Therapeutics (ELVN) | 0.0 | $2.9M | 115k | 25.54 | |
| Compass Therapeutics (CMPX) | 0.0 | $2.9M | 1.6M | 1.84 | |
| Wave Life Sciences SHS (WVE) | 0.0 | $2.8M | 344k | 8.20 | |
| Mersana Therapeutics (MRSN) | 0.0 | $2.1M | 1.1M | 1.89 | |
| NewAmsterdam Pharma Company Ordinary Shares (NAMS) | 0.0 | $1.6M | 97k | 16.60 | |
| Century Therapeutics (IPSC) | 0.0 | $1.4M | 798k | 1.71 | |
| vTv Therapeutics Cl A (VTVT) | 0.0 | $1.3M | 97k | 13.56 | |
| Aerovate Therapeutics (AVTE) | 0.0 | $1.3M | 629k | 2.09 | |
| Pfizer (PFE) | 0.0 | $1.0M | 35k | 28.94 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $982k | 537k | 1.83 | |
| Aligos Therapeutics | 0.0 | $719k | 83k | 8.66 | |
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $576k | 76k | 7.60 | |
| Pmv Pharmaceuticals (PMVP) | 0.0 | $480k | 322k | 1.49 | |
| Foghorn Therapeutics (FHTX) | 0.0 | $419k | 45k | 9.31 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.0 | $370k | 53k | 7.00 | |
| Tyra Biosciences (TYRA) | 0.0 | $249k | 11k | 23.51 | |
| Surrozen W Exp 8/11/2026 (SRZNW) | 0.0 | $8.6k | 833k | 0.01 |
